BioSpace News Archive

Press Releases

Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation

November 18, 2024
·
15 min read
Press Releases

Dante Genomics to Launch Generative AI Features in Dante Labs Whole Genome Platform

November 18, 2024
·
2 min read
Press Releases

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

November 18, 2024
·
11 min read
Press Releases

Lilly’s tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesity

November 18, 2024
·
22 min read
Press Releases

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial

November 18, 2024
·
7 min read
Press Releases

Theralase(R) Closes Non-Brokered Private Placement

November 18, 2024
·
5 min read
Press Releases

Opthea Appoints Kathy Connell to Board of Directors

November 18, 2024
·
6 min read
Press Releases

Bio-Path Holdings Reports Third Quarter 2024 Financial Results

November 18, 2024
·
8 min read
Press Releases

Idorsia’s once-daily TRYVIO™ (aprocitentan) is now available in the U.S., advancing treatment options for millions of patients with difficult-to-control hypertension

November 18, 2024
·
13 min read